share_log

Carisma Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

SEC ·  Apr 18, 2023 05:17
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.